This paper is part of the EMCDDA activity around the development and improvement of drug supply indicators, with a focus on drug-related homicide. It builds upon the 2017 review of the academic research and data sources on drug-related homicide at national and European/international levels by providing a common definition of the phenomenon and a detailed set of guidelines for standardised data collection. Importantly, the report also presents a comparative analysis of the results of the pilot collection of DRH data conducted in Finland, the Netherlands and Sweden.

This is a supporting publication to the 2019 EU Drug Markets Report.